Windtree Therapeutics Inc. /DE/ (WINT) intrinsic value & 10-year financials
Windtree Therapeutics Inc. /DE/ (WINT) has a Graham intrinsic value of $86.47 per share.
- Graham intrinsic value
- $86.47
- Share price (Oct 17, 2026)
- $0.00
- Market cap
- $1.0K
- Revenue (FY2024)
- —
- Revenue growth (10-yr CAGR)
- -33.1%
- ROIC (10-yr avg)
- -51.6%
- Free cash flow (FY2024)
- -$15.4M
WINT 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2024 | — | -$1.8M | — | -$15.4M | — | -572.4% |
| FY2023 | — | -$20.3M | — | -$13.5M | — | -723.1% |
| FY2022 | — | -$39.2M | — | -$19.5M | — | -295.1% |
| FY2021 | — | -$67.6M | — | -$23.9M | — | -180.9% |
| FY2020 | — | -$32.6M | — | -$25.6M | — | -57.2% |
| FY2019 | $198.0K | -$27.5M | — | -$24.9M | -12572.2% | -51.7% |
| FY2018 | $1.8M | -$20.5M | — | — | -905.8% | -92.9% |
| FY2017 | $1.5M | -$18.4M | -$24.14 | -$21.1M | -1518.4% | 195.9% |
| FY2016 | $2.0M | -$39.5M | -$4.74 | -$33.9M | -1862.7% | 531.0% |
| FY2015 | $987.0K | -$55.2M | -$7.98 | -$34.0M | -4035.9% | 730.1% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
WINDTREE THERAPEUTICS INC /DE/ revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
WINDTREE THERAPEUTICS INC /DE/ has historically struggled to out-earn its cost of capital, averaging just -20.5% ROIC.
Over the decade, WINDTREE THERAPEUTICS INC /DE/ shows that the company has leveraged its balance sheet to sustain operations.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, WINDTREE THERAPEUTICS INC /DE/ is modeled at -33.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $86.47 per share.